NuVasive, Inc. (NUVA) News
Filter NUVA News Items
NUVA News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
NUVA News Highlights
- NUVA's 30 day story count now stands at 4.
- Over the past 16 days, the trend for NUVA's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- The most mentioned tickers in articles about NUVA are GMED.
Latest NUVA News From Around the Web
Below are the latest news stories about NUVASIVE INC that investors may wish to consider to help them evaluate NUVA as an investment opportunity.
Here's Why You Should Retain Globus Medical (GMED) Stock NowInvestors continue to be optimistic about Globus Medical (GMED) based on the strong performances across geographies and the pending NuVasive acquisition. |
NuVasive (NUVA) Q1 Earnings Beat Estimates, Margins FallNuVasive's (NUVA) strong sales across the U.S. Spinal Hardware and U.S. Surgical Support businesses instill optimism. |
NuVasive (NUVA) Tops Q1 Earnings and Revenue EstimatesNuVasive (NUVA) delivered earnings and revenue surprises of 14.63% and 3.11%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock? |
NuVasive Announces First Quarter 2023 Financial ResultsNuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended March 31, 2023. |
Q1 2023 Globus Medical Inc Earnings CallQ1 2023 Globus Medical Inc Earnings Call |
Globus Medical (GMED) Q1 2023 Earnings Call TranscriptJoining today's call from Globus Medical will be Dan Scavilla, president and chief executive officer; and Keith Pfeil, chief financial officer. This review is being made available via webcast, accessible through the Investor Relations section of the Globus Medical website at www.globusmedical.com. |
NuVasive Announces Conference Call and Webcast of First Quarter 2023 ResultsNuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its first quarter 2023 results on Wednesday, May 10, 2023, after the close of the market. |
Is NuVasive, Inc.'s (NASDAQ:NUVA) ROE Of 4.7% Concerning?Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is... |
Is NuVasive (NUVA) a Great Value Stock Right Now?Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
Globus Medical Shareholders Approve Share Issuance for Merger with NuVasiveAUDUBON, Pa., April 27, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced that at the special meeting of shareholders held earlier today its shareholders voted to approve the issuance of shares of Globus Medical Class A common stock in connection with the proposed merger with NuVasive (NASDAQ: NUVA). As previously announced, under the terms of the merger agreement, Globus Medical will issue 0.75 of a share of Globus Medical Cl |